Systematic review and meta-analysis of adjunctive corticosteroids in the treatment of tuberculous pericarditis.

Author: GeorgeI A, SadhuJ S, ThomasB

Paper Details 
Original Abstract of the Article :
Tuberculosis (TB) is the most common cause of pericarditis worldwide and carries a high mortality, even with effective anti-tuberculosis treatment. In the light of a randomized control trial in 2014, the American Thoracic Society and the Centers for Disease Control and Prevention/Infectious Diseases...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5588/ijtld.17.0341

データ提供:米国国立医学図書館(NLM)

Adjunctive Corticosteroids for Tuberculous Pericarditis: A Controversial Approach

Tuberculous pericarditis, an inflammation of the sac surrounding the heart caused by tuberculosis, can be a life-threatening condition. Imagine a desert oasis, its water source threatened by a dangerous infection. This study examines the role of adjunctive corticosteroids in treating this potentially fatal illness.

A Shift in Perspective: Reassessing the Role of Corticosteroids

This systematic review and meta-analysis, a meticulous examination of existing research, provides a comprehensive overview of the use of corticosteroids in treating tuberculous pericarditis. The authors' findings suggest that routine use of corticosteroids might not be necessary in all cases, challenging previously held beliefs. The researchers, like skilled explorers, have meticulously examined the data, uncovering new insights into the treatment of this complex disease.

Navigating the Treatment Landscape: A New Approach

This study underscores the need for a more tailored approach to treating tuberculous pericarditis, where corticosteroids are used selectively based on individual patient needs rather than as a routine component of therapy. This nuanced approach, like a compass guiding travelers through a vast desert, allows doctors to make informed decisions that optimize patient outcomes.

Dr. Camel's Conclusion

This review is a valuable resource for clinicians treating tuberculous pericarditis, providing an evidence-based perspective on the use of corticosteroids. The authors' meticulous analysis prompts a shift in perspective, emphasizing the importance of individualized treatment plans tailored to each patient's unique needs.
Date :
  1. Date Completed 2019-06-24
  2. Date Revised 2019-06-24
Further Info :

Pubmed ID

29663961

DOI: Digital Object Identifier

10.5588/ijtld.17.0341

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.